Drug Target Review

FEBRUARY 19, 2024

I always found science fascinating, but I really fell in love with it in high school when I was introduced to biochemistry and molecular biology. It was then that I knew I wanted to dedicate my career to science. Biochemistry and molecular biology fascinated me in school. BECOME A ROLE MODEL!

Molecular Biology 110

Molecular Biology Science Protein Expression Production 110

Fierce BioTech

JUNE 6, 2023

Accelerating the Development of Nucleic Acid Therapies at Harwell Science and Innovation Campus Harwell Campus offers rich opportunities for pioneering NAT technology on all fronts, and the campus is attracting biotechnology companies of all sizes – from Moderna to start-ups to Government research institutes and accelerators. Download here!

Science 52

Science Therapies Molecular Biology Government 52

Drug Target Review

NOVEMBER 23, 2023

About the author Dr William Schafer Group Leader at MRC Laboratory of Molecular Biology William Schafer is a neuroscientist who has investigated conserved principles by which neurons and neural circuits control behaviour.

Therapies 98

Therapies Molecular Biology Laboratories Government 98

LifeSciVC

AUGUST 5, 2024

Earlier in my career, graduate-level molecular biology departments arose in universities at a time when those technologies were transformative to the science. That has largely fallen out of favor, and the technologies of molecular biology are today essential technical skills for the cell biologist and geneticist.

Molecular Biology 100

Molecular Biology Production Drug Development Small Molecule 100

Broad Institute

DECEMBER 13, 2023

Hung Group, Infectious Disease and Microbiome Program Michael Bogaev Princeton University Molecular Biology (major), B.A., Neuroscience (minor) Lander Lab Nina Gonzalez Bates University Biological Sciences (major), B.A., Neuroscience (minor) Lander Lab Nina Gonzalez Bates University Biological Sciences (major), B.A.,

Molecular Biology 52

Molecular Biology Cell Biology Science Engineering 52

DrugBank

MAY 15, 2024

This method was more about serendipity than science. But as molecular biology has advanced, so too has our approach to finding new drugs. Advancements in technology and a deeper understanding of molecular biology are beginning to turn the tide.

Small Molecule 98

Small Molecule Molecular Biology Drugs Disease 98

Broad Institute

APRIL 22, 2024

Jennifer Listgarten By Rose Circeo April 22, 2024 Jennifer Listgarten Jennifer Listgarten is a Professor in the Department of Electrical Engineering and Computer Science, the Center for Computational Biology, and the Bioengineering program at the University of California, Berkeley. She completed her Ph.D.

Molecular Biology 52

Molecular Biology Engineering Science Research 52

Drug Target Review

SEPTEMBER 22, 2023

Author Bio: Dr Han Wei Dr Han Wei is a Market Development Scientist at Beckman Coulter Life Sciences with a focus on building collaborative relationships with external partners. Prior to joining Beckman Coulter Life Sciences, she worked as a Research Associate and Postdoctoral Fellow at Indiana University School of Medicine.

Clinical Research 116

Clinical Research Research Drug Development Science 116

LifeSciVC

JULY 1, 2024

One thread that has run throughout it has been my passion for science as a lens for looking at the world. In particular, I love connecting science to daily life. Pfizer’s recent campaign around “ Science Will Win ” similarly appealed to the ethos of the power of science to help humanity. Remember life’s Central Dogma.

Science 92

Science Immune Response Molecular Biology RNA 92

Drug Target Review

APRIL 19, 2024

Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. And so, I have been the managerial co-founder and CEO of Sibylla since 2017. This multidisciplinary approach is at the heart of Sibylla.

Molecular Biology 111

Molecular Biology Research Pharmaceuticals Small Molecule 111

The Pharma Data

JANUARY 6, 2021

(“CytoDel” or “the Company”), a privately-held corporation, today announces the publication of preclinical data on the Company’s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. Südhof, M.D.,

Science 52

Science Molecular Biology Treatment Production 52

Drug Target Review

JUNE 5, 2025

Aaron Haubner, PhD, MBA is the Senior Manager, North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies Aaron earned his doctorate in pharmaceutical sciences and his MBA in finance.

Disease 52

Disease Treatment Therapies Nurses 52

Drug Target Review

MAY 27, 2024

Caris Life Sciences® (Caris) has been at the forefront of precision medicine. Caris Discovery, the therapeutic research arm of Caris Life Sciences, was launched to address the paucity of novel oncology drug targets and is uniquely poised to discover first-in-class ADC targets.

Clinical Trials 59

Clinical Trials Science Molecular Biology Bioinformatics 59

Drug Target Review

AUGUST 29, 2023

It’s also where I got exposed to career options beyond academia and learned about Flagship Pioneering, a venture creation firm that conceives, resources, and builds life science bio platform companies in health care and sustainability. One of my mentors asked me if I was ready to fail 90 percent of the time.

Science 98

Science Disease Molecular Biology Therapies 98

Drug Target Review

FEBRUARY 28, 2024

from 2003 to 2006, covering the biotechnology and life-science tools sectors. Mr. Ho was an inductee into the McMaster University Alumni Gallery in 2020 and currently serves as a member of their Dean’s Advisory Board for the Faculty of Science. Science 294(5542):605-609 (2001). in Biochemistry from McMaster University.

Therapies 105

Therapies Engineering Molecular Biology Science 105

Drug Target Review

NOVEMBER 8, 2023

He is also the President of the College of Sciences Alumni Board at Thomas Jefferson University. He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.

Therapies 116

Therapies Engineering Treatment Molecular Biology 116

Broad Institute

AUGUST 16, 2023

These large-scale biobanks with an open science philosophy are transforming what is possible in biomedical research and are accelerating the pace of discovery across the community,” Neale said.

DNA 98

DNA Molecular Biology Disease Regulations 98

Alta Sciences

JUNE 11, 2024

via Wikimedia Commons My fellow Altascientists and I recently attended the 2024 annual Boston Society Gene & Cell Therapy Conference , held at the wonderful Museum of Science in, of course, Boston, MA. Contact one of our experts today to discuss your gene therapy program.

Therapies 52

Therapies Molecular Biology Immune Response Science 52

Codon

JUNE 12, 2025

I walked away convinced that venture capital was too narrow an impact model for doing early-stage science, especially for industrial markets. funding to applied and basic research, you don’t have anywhere near that going into super science-y startups. Five years later, he gave the field the name it now goes by: molecular biology.

Government 64

Government Molecular Biology Research Production 64

DrugBank

FEBRUARY 9, 2023

1 Present address: Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Denmark. 2 Cancer Program, Broad Institute of MIT and Harvard, USA. 3 Research Focus: Network-based drug repositioning strategy to identify drugs targeting obesity and type 2 diabetes.

Clinical Pharmacology 52

Clinical Pharmacology Molecular Biology DNA Licensing 52

Drug Target Review

JUNE 11, 2024

When choosing my bachelor’s degree, the choice was between pursuing a career in biology or in computer science. Biology won that battle, and I pursued a bachelor’s and master’s degree in biochemistry and molecular biology. In math and life and physical sciences, women now make up nearly half of the workforce.

Engineering 64

Engineering Science Molecular Biology Doctors 64

Elrig

APRIL 29, 2024

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. During this time, I had the opportunity to step in as an interim Discovery Sciences project lead, sparking my interest in project leadership.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

NOVEMBER 23, 2020

The investigation into the smuggling activities is being led by China’s ministry of science and technology along with related authorities. as a director of molecular biology. Human genetic goods are tightly regulated by the Chinese government. Before joining GenScript, Zhu worked at California-based Clontech Laboratories, Inc.

Government 52

Government Molecular Biology Regulations Laboratories 52

The Pharma Data

SEPTEMBER 15, 2020

The companies will receive priority admission or renewal for one year of lab bench space with access to core facilities at the MBC BioLabs life sciences incubator, including access to Amgen ‘s scientific experts and business leaders to help advance their scientific programs.

Targeted Protein Degradation 52

Targeted Protein Degradation Molecular Biology Science Small Molecule 52

Alta Sciences

AUGUST 21, 2024

I have also learned a lot about the nuances of micropipettes that I would have never learned at school.” — Sheridan Moore , Research Associate Intern, Laboratory Sciences “My favorite part about interning at Altasciences is the potential for creating a long, meaningful career that I would be passionate about.

International 40

International Laboratories Science Molecular Biology 40

Broad Institute

OCTOBER 16, 2024

It is so important to recognize groundbreaking science and the remarkable individuals who have made a difference so more people are aware of these achievements," said Edythe Broad. "If He has a humble, self-effacing demeanor, and yet he is great at pushing people to make bold bets and to try to make the impossible possible."

Vaccine 64

Vaccine RNA Laboratories Molecular Biology 64

Drug Target Review

JUNE 19, 2024

Mr Culley has more than 30 years of business and scientific experience in the life sciences industry. He received a BS in biology from Boston College, a masters in biochemistry and molecular biology from the University of California, Santa Barbara, and an M.B.A. from May 2017 until December 2022.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

Drug Target Review

OCTOBER 25, 2024

At Johnson & Johnson, our differentiated Alzheimer’s disease research program is focused on leveraging the latest advancements in precision medicine, data science and digital health to help make earlier diagnosis an option and help treat the right patient with the right treatment at the right time. link] Pugazhenthi, S. 2017, February 4).

Disease 59

Disease Clinical Trials Therapies Science 59

Drug Target Review

FEBRUARY 26, 2024

She moved to Johns Hopkins in 1999 as an Assistant Professor of Oncology, Dermatology, and Molecular Biology and Genetics and was promoted to Associate Professor in 2004. Dr Alani further developed her research interests as a research fellow at Memorial Sloan-Kettering Cancer Center.

Therapies 59

Therapies Molecular Biology Medical Schools Regulations 59

Elrig

APRIL 6, 2023

Ron discussed three major challenges when developing an organoid model for drug discovery work, as well as taking Artificial Intelligence and neuronal networks full circle, using molecular biology to engineer logic switches in hiPSCs. Congratulations to all our award winners.

Research 40

Research Molecular Biology Science Drugs 40

The Pharma Data

JANUARY 18, 2021

Fox Foundation continues to fund our cutting-edge science in their mission to transform the way new Parkinson’s disease treatments are developed and tested,” says Dr. Charlotte D’Hulst, CEO & Co-Founder of Yesse Technologies, Inc. “We are thrilled that The Michael J.

Disease 40

Disease Molecular Biology Licensing Licensing 40

Alta Sciences

MARCH 1, 2024

PJ: At Altasciences, we have a range of leading-edge platforms that include ligand binding assays (LBA), NAb, TAb, flow cytometry, and ELISpot, as well as on-site molecular biology instrumentation such as Bio-Rad’s ddPCR system, the NanoDropTM One spectrophotometer, and dedicated polymerase chain reaction (PCR) chambers.

Therapies 52

Therapies Laboratories Molecular Biology RNA 52

The Pharma Data

NOVEMBER 22, 2021

State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem Sustainable environmental engineering aligned to Company’s zero carbon future. Over the once century, roughly 50 Nobel Prize winners in chemistry and physiology or drug have been associated with Cambridge.

Molecular Biology 52

Molecular Biology Laboratories Engineering Hospitals 52

The Pharma Data

OCTOBER 18, 2020

NASDAQ:CDXC) today highlighted a new study published in The European Molecular Biology Organization Journal looking at the effect of nicotinamide riboside (NR) on maintaining telomeres, the protective regions at the end of DNA strands. is a science-based integrated nutraceutical company devoted to improving the way people age.

DNA 52

DNA Molecular Biology Disease Trials 52

Drug Target Review

AUGUST 29, 2024

He is also the president of the College of Sciences Alumni Board at Thomas Jefferson University. He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.

Therapies 59

Therapies Treatment Engineering Molecular Biology 59

The Pharma Data

JANUARY 4, 2021

Barber is an associate professor of biology and director of the Office of Student Research. Dr. Barber is in her tenth year at Longwood and serves as the President-Elect of the Virginia Academy of Science. Dr. Barber is a tumor immunologist. She is an expert in chimeric antigen T-cells. About Longwood University.

Therapies 40

Therapies Molecular Biology Immune Response Science 40

The Pharma Data

NOVEMBER 19, 2020

The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of Molecular Biology. Zhang, et al, Science (2020) DOI: 10.1126/science.abb3405. References. Hilgenfeld, Febs J.

Small Molecule 40

Small Molecule Structure Based Drug Design (SBDD) Molecular Biology International 40